FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022941639> ?p ?o ?g. }

• W3022941639 endingPage "889" @default.
• W3022941639 startingPage "889" @default.
• W3022941639 abstract "The majority of the clinically approved iron oxide nanoparticles (IO NPs) used as contrast agents for magnetic resonance imaging (MRI) have been withdrawn from the market either due to safety concerns or lack of profits. To address this challenge, liposomes have been used to prepare IO-based T2 contrast agents. We studied the influence of different phospholipids on the relaxivity (r2) values of magneto-liposomes (MLs) containing magnetic NPs in the bilayer, where a strong correlation between the bilayer fluidity and r2 is clearly shown. Embedding 5-nm IO NPs in the lipid bilayer leads to a significant improvement in their relaxivity, where r2 values range from 153 ± 5 s-1 mM-1 for DPPC/cholesterol/DSPE-PEG (96/50/4) up to 673 ± 12 s-1 mM-1 for DOPC/DSPE-PEG (96/4), compared to free IO NPs with an r2 value of 16 s-1 mM-1, measured at 9.4 T MRI scanner. In vitro MRI measurements, together with the ICP-MS analysis, revealed MLs as highly selective contrast agents that were preferentially taken up by cancerous T24 cells, which led to an improvement in the contrast and an easier distinction between the healthy and the cancerous cells. A careful selection of the lipid bilayer to prepare MLs could offer efficient MRI contrast agents, even at very low IO NP concentrations." @default.
• W3022941639 created "2020-05-13" @default.
• W3022941639 creator A5000367231 @default.
• W3022941639 creator A5004975546 @default.
• W3022941639 creator A5005916320 @default.
• W3022941639 creator A5028401323 @default.
• W3022941639 creator A5043097979 @default.
• W3022941639 creator A5048080032 @default.
• W3022941639 creator A5061849146 @default.
• W3022941639 creator A5085509588 @default.
• W3022941639 date "2020-05-06" @default.
• W3022941639 modified "2023-10-15" @default.
• W3022941639 title "Magneto-Liposomes as MRI Contrast Agents: A Systematic Study of Different Liposomal Formulations" @default.
• W3022941639 cites W165024400 @default.
• W3022941639 cites W1792165776 @default.
• W3022941639 cites W1867757591 @default.
• W3022941639 cites W1968257327 @default.
• W3022941639 cites W1984232298 @default.
• W3022941639 cites W1987843843 @default.
• W3022941639 cites W1988329232 @default.
• W3022941639 cites W1990857187 @default.
• W3022941639 cites W1999955776 @default.
• W3022941639 cites W2004426884 @default.
• W3022941639 cites W2005855224 @default.
• W3022941639 cites W2020214628 @default.
• W3022941639 cites W2021024674 @default.
• W3022941639 cites W2021867728 @default.
• W3022941639 cites W2025363480 @default.
• W3022941639 cites W2033503179 @default.
• W3022941639 cites W2035013707 @default.
• W3022941639 cites W2037458039 @default.
• W3022941639 cites W2039985275 @default.
• W3022941639 cites W2041602422 @default.
• W3022941639 cites W2043768129 @default.
• W3022941639 cites W2049169201 @default.
• W3022941639 cites W2065725244 @default.
• W3022941639 cites W2072534801 @default.
• W3022941639 cites W2095280826 @default.
• W3022941639 cites W2115040835 @default.
• W3022941639 cites W2140588732 @default.
• W3022941639 cites W2147598341 @default.
• W3022941639 cites W2149036628 @default.
• W3022941639 cites W2151107007 @default.
• W3022941639 cites W2156821175 @default.
• W3022941639 cites W2161536039 @default.
• W3022941639 cites W2166173762 @default.
• W3022941639 cites W2170017105 @default.
• W3022941639 cites W2174019711 @default.
• W3022941639 cites W2184022143 @default.
• W3022941639 cites W2267660839 @default.
• W3022941639 cites W2316142734 @default.
• W3022941639 cites W2322891651 @default.
• W3022941639 cites W2484864872 @default.
• W3022941639 cites W2499172676 @default.
• W3022941639 cites W2508413003 @default.
• W3022941639 cites W2554694448 @default.
• W3022941639 cites W2593812550 @default.
• W3022941639 cites W2605626462 @default.
• W3022941639 cites W2773966163 @default.
• W3022941639 cites W2802045560 @default.
• W3022941639 cites W2802294329 @default.
• W3022941639 cites W2907202911 @default.
• W3022941639 cites W2908969207 @default.
• W3022941639 cites W2910429314 @default.
• W3022941639 cites W4251109426 @default.
• W3022941639 cites W789380907 @default.
• W3022941639 doi "https://doi.org/10.3390/nano10050889" @default.
• W3022941639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7279489" @default.
• W3022941639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32384645" @default.
• W3022941639 hasPublicationYear "2020" @default.
• W3022941639 type Work @default.
• W3022941639 sameAs 3022941639 @default.
• W3022941639 citedByCount "25" @default.
• W3022941639 countsByYear W30229416392020 @default.
• W3022941639 countsByYear W30229416392021 @default.
• W3022941639 countsByYear W30229416392022 @default.
• W3022941639 countsByYear W30229416392023 @default.
• W3022941639 crossrefType "journal-article" @default.
• W3022941639 hasAuthorship W3022941639A5000367231 @default.
• W3022941639 hasAuthorship W3022941639A5004975546 @default.
• W3022941639 hasAuthorship W3022941639A5005916320 @default.
• W3022941639 hasAuthorship W3022941639A5028401323 @default.
• W3022941639 hasAuthorship W3022941639A5043097979 @default.
• W3022941639 hasAuthorship W3022941639A5048080032 @default.
• W3022941639 hasAuthorship W3022941639A5061849146 @default.
• W3022941639 hasAuthorship W3022941639A5085509588 @default.
• W3022941639 hasBestOaLocation W30229416391 @default.
• W3022941639 hasConcept C120665830 @default.
• W3022941639 hasConcept C121332964 @default.
• W3022941639 hasConcept C126838900 @default.
• W3022941639 hasConcept C143409427 @default.
• W3022941639 hasConcept C171250308 @default.
• W3022941639 hasConcept C178790620 @default.
• W3022941639 hasConcept C185154212 @default.
• W3022941639 hasConcept C185592680 @default.
• W3022941639 hasConcept C192157962 @default.
• W3022941639 hasConcept C192562407 @default.
• W3022941639 hasConcept C2776502983 @default.

• next